The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Cytokines in the pathogenesis of rheumatoid arthritis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130
Bone Resorption by Osteoclasts
Teitelbaum, S. L. (2000) · Science · doi:10.1126/science.289.5484.1504 · Cited by 3,962
Evolving concepts of rheumatoid arthritis
Firestein, G. S. (2003) · Nature · doi:10.1038/nature01661 · Cited by 3,605
Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis
Edwards, J. C. W., Szczepański, L., Szechiński, J., Filipowicz-Sosnowska, A., Emery, P., Close, D. R., Stevens, R. M., & Shaw, T. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032534 · Cited by 2,623
ROLE OF CYTOKINES IN RHEUMATOID ARTHRITIS
Feldmann, M., Brennan, F. M., & Maini, R. N. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.397 · Cited by 2,514
Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis
Zheng, Y., Danilenko, D. M., Valdez, P., Kasman, I., Eastham-Anderson, J., Wu, J., & Ouyang, W. (2007) · Nature · doi:10.1038/nature05505 · Cited by 1,862
Kong, Y.-Y., Feige, U., Sarosi, I., Bolon, B., Tafuri, A., Morony, S., Capparelli, C., Li, J., Elliott, R., McCabe, S., et al. (1999) · Nature · doi:10.1038/46303 · Cited by 1,856
IL-17 family cytokines and the expanding diversity of effector T cell lineages
Weaver, C. T., Hatton, R. D., Mangan, P. R., & Harrington, L. E. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141557 · Cited by 1,842
Yoshida, H., Hayashi, S.-I., Kunisada, T., Ogawa, M., Nishikawa, S., Okamura, H., Sudo, T., Shultz, L. D., & Nishikawa, S.-I. (1990) · Nature · doi:10.1038/345442a0 · Cited by 1,789
Kotake, S., Udagawa, N., Takahashi, N., Matsuzaki, K., Itoh, K., Ishiyama, S., Saito, S., Inoue, K., Kamatani, N., Gillespie, M. T., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5703 · Cited by 1,696
Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune Inflammation
Murphy, C. A., Langrish, C. L., Chen, Y., Blumenschein, W., McClanahan, T., Kastelein, R. A., Sedgwick, J. D., & Cua, D. J. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030896 · Cited by 1,669
Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis.
Keffer, J., Probert, L., Cazlaris, H., Georgopoulos, S., Kaslaris, E., Kioussis, D., & Kollias, G. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04978.x · Cited by 1,660
Sato, K., Suematsu, A., Okamoto, K., Yamaguchi, A., Morishita, Y., Kadono, Y., Tanaka, S., Kodama, T., Akira, S., Iwakura, Y., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061775 · Cited by 1,554
Goekoop‐Ruiterman, Y. P. M., De Vries‐Bouwstra, J. K., Allaart, C. F., Van Zeben, D., Kerstens, P. J. S. M., Hazes, J. M. W., Zwinderman, A. H., Ronday, H. K., Han, K. H., Westedt, M. L., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21405 · Cited by 1,460
Lam, J., Takeshita, S., Barker, J. E., Kanagawa, O., Ross, F. P., & Teitelbaum, S. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11176 · Cited by 1,440 · cited 1×
“TNF is a potent driver of osteoclast formation, acting either additively with RANK”
BackgroundBertolini, D. R., Nedwin, G. E., Bringman, T. S., Smith, D. D., & Mundy, G. R. (1986) · Nature · doi:10.1038/319516a0 · Cited by 1,434
Steinman, L. (2007) · Nature Medicine · doi:10.1038/nm1551 · Cited by 1,376
T-Cell mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ.
Takayanagi, H., Ogasawara, K., Hida, S., Chiba, T., Murata, S., Sato, K., Takaoka, A., Yokochi, T., Oda, H., Tanaka, K., et al. (2000) · Nature · doi:10.1038/35046102 · Cited by 1,358
Dickkopf-1 is a master regulator of joint remodeling
Diarra, D., Stolina, M., Polzer, K., Zwerina, J., Ominsky, M. S., Dwyer, D., Korb, A., Smolen, J., Hoffmann, M., Scheinecker, C., et al. (2007) · Nature Medicine · doi:10.1038/nm1538 · Cited by 1,298
Self-citationCompromised Function of Regulatory T Cells in Rheumatoid Arthritis and Reversal by Anti-TNFα Therapy
Ehrenstein, M. R., Evans, J. G., Singh, A., Moore, S., Warnes, G., Isenberg, D. A., & Mauri, C. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040165 · Cited by 1,252
Abatacept for Rheumatoid Arthritis Refractory to Tumor Necrosis Factor α Inhibition
Genovese, M. C., Becker, J.-C., Schiff, M., Luggen, M., Sherrer, Y., Kremer, J., Birbara, C., Box, J., Natarajan, K., Nuamah, I., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050524 · Cited by 1,241
Kelley's Textbook of Rheumatology
(2013) · Elsevier eBooks · doi:10.1016/c2009-1-62542-9 · Cited by 1,101
Feldmann, M., Brennan, F. M., & Maini, R. N. (1996) · Cell · doi:10.1016/s0092-8674(00)81109-5 · Cited by 970
Stumhofer, J. S., Laurence, A., Wilson, E. H., Huang, E., Tato, C. M., Johnson, L. M., Villarino, A. V., Huang, Q., Yoshimura, A., Sehy, D., et al. (2006) · Nature Immunology · doi:10.1038/ni1376 · Cited by 955
Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium
Chabaud, M., Durand, J. M., Buchs, N., Fossiez, F., Page, G., Frappart, L., & Miossec, P. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199905)42:5<963::aid-anr15>3.0.co;2-e · Cited by 954
Explaining How “High-Grade” Systemic Inflammation Accelerates Vascular Risk in Rheumatoid Arthritis
Sattar, N., McCarey, D. W., Capell, H., & McInnes, I. B. (2003) · Circulation · doi:10.1161/01.cir.0000099844.31524.05 · Cited by 942
Self-citationCCR5 is characteristic of Th1 lymphocytes
Loetscher, P., Uguccioni, M., Bordoli, L., Baggiolini, M., Moser, B., Chizzolini, C., & Dayer, J.-M. (1998) · Nature · doi:10.1038/34814 · Cited by 866
Batten, M., Li, J., Yi, S., Kljavin, N. M., Danilenko, D. M., Lucas, S., Lee, J., de Sauvage, F. J., & Ghilardi, N. (2006) · Nature Immunology · doi:10.1038/ni1375 · Cited by 825
IL-1 mediates TNF-induced osteoclastogenesis
Wei, S., Kitaura, H., Zhou, P., Ross, F. P., & Teitelbaum, S. L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523394 · Cited by 795
Mast Cells: A Cellular Link Between Autoantibodies and Inflammatory Arthritis
Lee, D. M., Friend, D. S., Gurish, M. F., Benoist, C., Mathis, D., & Brenner, M. B. (2002) · Science · doi:10.1126/science.1073176 · Cited by 750
Horai, R., Saijo, S., Tanioka, H., Nakae, S., Sudo, K., Okahara, A., Ikuse, T., Asano, M., & Iwakura, Y. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.2.313 · Cited by 749
Lymphoid Neogenesis in Rheumatoid Synovitis
Takemura, S., Braun, A., Crowson, C., Kurtin, P. J., Cofield, R. H., O’Fallon, W. M., Goronzy, J. J., & Weyand, C. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.2.1072 · Cited by 660
Interleukin 6: from bench to bedside
Nishimoto, N., & Kishimoto, T. (2006) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0338 · Cited by 642
A proinflammatory role for IL-18 in rheumatoid arthritis
Gracie, J. A., Forsey, R. J., Chan, W. L., Gilmour, A., Leung, B. P., Greer, M. R., Kennedy, K., Carter, R., Wei, X.-Q., Xu, D., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7317 · Cited by 636
Self-citationRitchlin, C. T., Haas-Smith, S. A., Li, P., Hicks, D. G., & Schwarz, E. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16069 · Cited by 616
Interleukin 6 is required for the development of collagen-induced arthritis
Alonzi, T., Fattori, E., Lazzaro, D., Costa, P., Probert, L., Kollias, G., De Benedetti, F., Poli, V., & Ciliberto, G. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.4.461 · Cited by 604
Hoffman, H. M., Rosengren, S., Boyle, D. L., Cho, J. Y., Nayar, J., Mueller, J. L., Anderson, J. P., Wanderer, A. A., & Firestein, G. S. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17401-1 · Cited by 552
T Cell Activation in Rheumatoid Synovium Is B Cell Dependent
Takemura, S., Klimiuk, P. A., Braun, A., Goronzy, J. J., & Weyand, C. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.8.4710 · Cited by 536
Osteoclasts are essential for TNF-α–mediated joint destruction
Redlich, K., Hayer, S., Ricci, R., David, J.-P., Tohidast-Akrad, M., Kollias, G., Steiner, G., Smolen, J. S., Wagner, E. F., & Schett, G. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15582 · Cited by 531
Self-citationQuinn, M. A., Conaghan, P. G., O'Connor, P. J., Karim, Z., Greenstein, A., Brown, A., Brown, C., Fraser, A., Jarret, S., & Emery, P. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20712 · Cited by 529
Raza, K., Falciani, F., Curnow, S. J., Ross, E. J., Lee, C.-Y., Akbar, A. N., Lord, J. M., Gordon, C., Buckley, C. D., & Salmon, M. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1733 · Cited by 515
McInnes, I. B., Leung, B. P., Sturrock, R. D., Field, M., & Liew, F. Y. (1997) · Nature Medicine · doi:10.1038/nm0297-189 · Cited by 512
Self-citationNadkarni, S., Mauri, C., & Ehrenstein, M. R. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061531 · Cited by 507
Pettipher, E. R., Higgs, G. A., & Henderson, B. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.22.8749 · Cited by 496
Hirota, K., Hashimoto, M., Yoshitomi, H., Tanaka, S., Nomura, T., Yamaguchi, T., Iwakura, Y., Sakaguchi, N., & Sakaguchi, S. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062259 · Cited by 482
Osteoclasts are essential for TNF-α-mediated joint destruction.
Redlich, K., Hayer, S., Ricci, R., David, J.-P., Tohidast-Akrad, M., Kollias, G., Steiner, G., Smolen, J. S., Wagner, E. F., & Schett, G. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215582 · Cited by 474
Self-citationFibroblast biology. Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis.
Pap, T., Müller-Ladner, U., Gay, R. E., & Gay, S. (2000) · Arthritis Research · doi:10.1186/ar113 · Cited by 472
Horwood, N. J. (1998) · Endocrinology · doi:10.1210/en.139.11.4743 · Cited by 461
Accelerated collagen-induced arthritis in IFN-gamma receptor-deficient mice
Vermeire, K., Heremans, H., Vandeputte, M., Huang, S., Billiau, A., & Matthys, P. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.11.5507 · Cited by 458
The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models.
Lubberts, E., Koenders, M. I., & van den Berg, W. B. (2005) · Arthritis Research · doi:10.1186/ar1478 · Cited by 438
Schröder, A. E., Greiner, A., Seyfert, C., & Berek, C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.221 · Cited by 434
Cadherin-11 in Synovial Lining Formation and Pathology in Arthritis
Lee, D. M., Kiener, H. P., Agarwal, S. K., Noss, E. H., Watts, G. F. M., Chisaka, O., Takeichi, M., & Brenner, M. B. (2007) · Science · doi:10.1126/science.1137306 · Cited by 420
Expression of interleukin‐22 in rheumatoid arthritis: Potential role as a proinflammatory cytokine
Ikeuchi, H., Kuroiwa, T., Hiramatsu, N., Kaneko, Y., Hiromura, K., Ueki, K., & Nojima, Y. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20965 · Cited by 399
Udagawa, N., Horwood, N. J., Elliott, J., Mackay, A., Owens, J., Okamura, H., Kurimoto, M., Chambers, T. J., Martin, T. J., & Gillespie, M. T. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.6.1005 · Cited by 378
Anti-Cytokine Therapy for Rheumatoid Arthritis
Maini, R. N., & Taylor, P. C. (2000) · Annual Review of Medicine · doi:10.1146/annurev.med.51.1.207 · Cited by 376
Angiogenesis in rheumatoid arthritis.
Paleolog, E. M. (2002) · Arthritis Research · doi:10.1186/ar575 · Cited by 363
High susceptibility to collagen-induced arthritis in mice lacking IFN-gamma receptors
Manoury-Schwartz, B., Chiocchia, G., Bessis, N., Abehsira-Amar, O., Batteux, F., Muller, S., Huang, S., Boissier, M. C., & Fournier, C. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.11.5501 · Cited by 355
MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis
Morand, E. F., Leech, M., & Bernhagen, J. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2029 · Cited by 351
The role of the T cell in autoimmune inflammation.
Skapenko, A., Leipe, J., Lipsky, P. E., & Schulze‐Koops, H. (2005) · Arthritis Research · doi:10.1186/ar1703 · Cited by 337
IL-32, a proinflammatory cytokine in rheumatoid arthritis
Joosten, L. A. B., Netea, M. G., Kim, S.-H., Yoon, D.-Y., Oppers-Walgreen, B., Radstake, T. R. D., Barrera, P., van de Loo, F. A. J., Dinarello, C. A., & van den Berg, W. B. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511233103 · Cited by 334
Seeing the wood for the trees: the forgotten role of neutrophils in rheumatoid arthritis
Edwards, S. W., & Hallett, M. B. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)01087-6 · Cited by 323
van der Pouw Kraan, T. C. T. M., Wijbrandts, C. A., van Baarsen, L. G. M., Voskuyl, A. E., Rustenburg, F., Baggen, J. M., Ibrahim, S. M., Fero, M., Dijkmans, B. A. C., Tak, P. P., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.063412 · Cited by 313
High mobility group box chromosomal protein 1: A novel proinflammatory mediator in synovitis
Kokkola, R., Sundberg, E., Ulfgren, A. ‐., Palmblad, K., Li, J., Wang, H., Ulloa, L., Yang, H., Yan, X. ‐., Furie, R., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10540 · Cited by 290
Netea, M. G., Azam, T., Ferwerda, G., Girardin, S. E., Walsh, M., Park, J.-S., Abraham, E., Kim, J.-M., Yoon, D.-Y., Dinarello, C. A., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508237102 · Cited by 289
Expression and Regulation of Toll-Like Receptor 2 in Rheumatoid Arthritis Synovium
Seibl, R., Birchler, T., Loeliger, S., Hossle, J. P., Gay, R. E., Saurenmann, T., Michel, B. A., Seger, R. A., Gay, S., & Lauener, R. P. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63918-1 · Cited by 287
The balance of Th1/Th2 cytokines in rheumatoid arthritis
Schulze-Koops, H., & Kalden, J. R. (2001) · Best Practice & Research Clinical Rheumatology · doi:10.1053/berh.2001.0187 · Cited by 275
Wong, P. K. K., Quinn, J. M. W., Sims, N. A., van Nieuwenhuijze, A., Campbell, I. K., & Wicks, I. P. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21537 · Cited by 270
BLyS and APRIL in rheumatoid arthritis
Seyler, T. M. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25265 · Cited by 266
Targeting interleukin‐15 in patients with rheumatoid arthritis: A proof‐of‐concept study
Baslund, B., Tvede, N., Danneskiold‐Samsoe, B., Larsson, P., Panayi, G., Petersen, J., Petersen, L. J., Beurskens, F. J. M., Schuurman, J., van de Winkel, J. G. J., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21249 · Cited by 265
Self-citationMiossec, P. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10816 · Cited by 264
Manzo, A., Paoletti, S., Carulli, M., Blades, M. C., Barone, F., Yanni, G., FitzGerald, O., Bresnihan, B., Caporali, R., Montecucco, C., et al. (2005) · European Journal of Immunology · doi:10.1002/eji.200425830 · Cited by 251
Chemokines and their receptors in rheumatoid arthritis: Future targets?
Koch, A. E. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20932 · Cited by 247
Ectopic Germinal Center Formation in Rheumatoid Synovitis
WEYAND, C. M., & GORONZY, J. J. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb06042.x · Cited by 241
High-Sensitivity C-Reactive Protein and Risk of Nontraumatic Fractures in the Bruneck Study
Schett, G. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.22.2495 · Cited by 228
Self-citationLi, P., Schwarz, E. M., O'Keefe, R. J., Ma, L., Boyce, B. F., & Xing, L. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.0301233 · Cited by 220
Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritis
Paniagua, R. T. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28546 · Cited by 220
Joosten, L. A. B., Koenders, M. I., Smeets, R. L., Heuvelmans-Jacobs, M., Helsen, M. M. A., Takeda, K., Akira, S., Lubberts, E., van de Loo, F. A. J., & van den Berg, W. B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.11.6145 · Cited by 216
Eberhardt, W., Huwiler, A., Beck, K.-F., Walpen, S., & Pfeilschifter, J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.10.5788 · Cited by 213
Ohata, J., Zvaifler, N. J., Nishio, M., Boyle, D. L., Kalled, S. L., Carson, D. A., & Kipps, T. J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.2.864 · Cited by 211
Smoking as a trigger for inflammatory rheumatic diseases
Klareskog, L., Padyukov, L., & Alfredsson, L. (2007) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32801127c8 · Cited by 211
A subset of natural killer cells is greatly expanded within inflamed joints
Dalbeth, N., & Callan, M. F. C. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10410 · Cited by 210
Yumoto, K., Ishijima, M., Rittling, S. R., Tsuji, K., Tsuchiya, Y., Kon, S., Nifuji, A., Uede, T., Denhardt, D. T., & Noda, M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052523599 · Cited by 207
Choe, J.-Y., Crain, B., Wu, S. R., & Corr, M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021850 · Cited by 195
Therapeutic Promise of Proteinase-Activated Receptor-2 Antagonism in Joint Inflammation
Kelso, E. B., Lockhart, J. C., Hembrough, T., Dunning, L., Plevin, R., Hollenberg, M. D., Sommerhoff, C. P., McLean, J. S., & Ferrell, W. R. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.093807 · Cited by 194
Burger, J. A., Zvaifler, N. J., Tsukada, N., Firestein, G. S., & Kipps, T. J. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11092 · Cited by 190
CD8 T Cells Are Required for the Formation of Ectopic Germinal Centers in Rheumatoid Synovitis
Kang, Y. M., Zhang, X., Wagner, U. G., Yang, H., Beckenbaugh, R. D., Kurtin, P. J., Goronzy, J. J., & Weyand, C. M. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011565 · Cited by 186
Sacre, S. M., Andreakos, E., Kiriakidis, S., Amjadi, P., Lundberg, A., Giddins, G., Feldmann, M., Brennan, F., & Foxwell, B. M. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.060657 · Cited by 184
Firestein, G. S., & Zvaifler, N. J. (1987) · Arthritis & Rheumatism · doi:10.1002/art.1780300804 · Cited by 175
The role of Toll-like receptor signalling in the pathogenesis of arthritis
Brentano, F., Kyburz, D., Schorr, O., Gay, R., & Gay, S. (2005) · Cellular Immunology · doi:10.1016/j.cellimm.2005.04.018 · Cited by 165
Role of osteopontin in amplification and perpetuation of rheumatoid synovitis.
Xu, G., Nie, H., Li, N.-L., Zheng, W., Zhang, D.-Q., Feng, G., Ni, L., Xu, R., Hong, J., & Zhang, J.-W. Z. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23273 · Cited by 159
Lubberts, E., Joosten, L. A. B., van de Loo, F. A. J., Schwarzenberger, P. O., Kolls, J., & van den Berg, W. B. (2002) · Inflammation Research · doi:10.1007/bf02684010 · Cited by 152
Ferrari‐Lacraz, S., Zanelli, E. H., Neuberg, M., Donskoy, E., Kim, Y. S., Zheng, X. X., Hancock, W. W., Maśliński, W., Li, X. C., Strom, T. B., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.9.5818 · Cited by 141
Interaction between Synovial Inflammatory Tissue and Bone Marrow in Rheumatoid Arthritis
Jimenez‐Boj, E., Redlich, K., Türk, B., Hanslik‐Schnabel, B., Wanivenhaus, A. H., Chott, A., Smolen, J. S., & Schett, G. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.4.2579 · Cited by 140
Self-citationCytokine networks—towards new therapies for rheumatoid arthritis
McInnes, I. B., & Liew, F. Y. (2005) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0020 · Cited by 138
Self-citationHigh-Sensitivity C-Reactive Protein and Fracture Risk in Elderly Women
Pasco, J. A., Kotowicz, M. A., Henry, M. J., Nicholson, G. C., Spilsbury, H. J., Box, J. D., & Schneider, H. G. (2006) · JAMA · doi:10.1001/jama.296.11.1353 · Cited by 134
Cell-cell interactions in synovitis. Interactions between T lymphocytes and synovial cells.
McInnes, I. B., Leung, B. P. L., & Liew, F. Y. (2000) · Arthritis Research · doi:10.1186/ar115 · Cited by 134
Self-citationThe Mast Cell in Inflammatory Arthritis
Woolley, D. E. (2003) · New England Journal of Medicine · doi:10.1056/nejmcibr023206 · Cited by 132
PATHWAYS BY WHICH INTERLEUKIN 17 INDUCES ARTICULAR CARTILAGE BREAKDOWN IN VITRO AND IN VIVO
Cai, L., Yin, J., Starovasnik, M. A., Hogue, D. A., Hillan, K. J., Mort, J. S., & Filvaroff, E. H. (2001) · Cytokine · doi:10.1006/cyto.2001.0939 · Cited by 123
Lindhout, E., van Eijk, M., van Pel, M., Lindeman, J., Dinant, H. J., & de Groot, C. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.10.5949 · Cited by 121
Transcription factor T-bet regulates inflammatory arthritis through its function in dendritic cells
Wang, J. H. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26631 · Cited by 121
Isomäki, P., Panesar, M., Annenkov, A. E., Clark, J. M., Foxwell, B. M. J., Chernajovsky, Y., & Cope, A. P. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.9.5495 · Cited by 119
Understanding the genetic contribution to rheumatoid arthritis
Mil, A. H. M. V. D. H., Wesoły, J., & Huizinga, T. W. J. (2005) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000160780.13012.be · Cited by 119
Inflammatory Mediators as Essential Elements in Bone Remodeling
Goldring, S. R. (2003) · Calcified Tissue International · doi:10.1007/s00223-002-1049-y · Cited by 114
Interleukin-18 Promotes Joint Inflammation and Induces Interleukin-1-Driven Cartilage Destruction
Joosten, L. A. B., Smeets, R. L., Koenders, M. I., van den Bersselaar, L. A. M., Helsen, M. M. A., Oppers‐Walgreen, B., Lubberts, E., Iwakura, Y., van de Loo, F. A. J., & van den Berg, W. B. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63357-3 · Cited by 86
Bresnihan, B. (2001) · Seminars in Arthritis and Rheumatism · doi:10.1053/sarh.2001.23701 · Cited by 85
Kelso, E. B., Ferrell, W. R., Lockhart, J. C., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22423 · Cited by 85
Targeting interleukin‐1 in the treatment of rheumatoid arthritis
Dayer, J., & Bresnihan, B. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10168 · Cited by 80
VEYS, E. M., Menkès, C.-J., & Emery, P. E. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400110 · Cited by 78
Effect of interleukin 17 on proteoglycan degradation in murine knee joints
Dudler, J., Renggli-Zulliger, N., Busso, N., Lotz, M., & So, A. (2000) · Annals of the Rheumatic Diseases · doi:10.1136/ard.59.7.529 · Cited by 78
Seitz, M., Loetscher, P., Fey, M. F., & Tobler, A. (1994) · Lara D. Veeken · doi:10.1093/rheumatology/33.7.613 · Cited by 72
T-cell-targeted therapies in rheumatoid arthritis
Weyand, C. M., & Goronzy, J. J. (2006) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0142 · Cited by 70
Inhibition of angiogenic pathways in rheumatoid arthritis: potential for therapeutic targeting
Veale, D. J., & Fearon, U. (2006) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2006.05.004 · Cited by 68
Interleukin-18: a therapeutic target in rheumatoid arthritis?
McInnes, I. B., Liew, F. Y., & Gracie, J. A. (2005) · Arthritis Research · doi:10.1186/ar1497 · Cited by 62
Self-citationLymphotoxin β–mediated stimulation of synoviocytes in rheumatoid arthritis
Braun, A. B., Takemura, S., Vallejo, A. N., Goronzy, J. J., & Weyand, C. M. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20356 · Cited by 60
Ks, K., Hagiwara, E., Yarboro, C. H., Schumacher, H. R., Rl, W., & Dm, K. (1998) · PubMed · Cited by 54
Lessons from animal models of arthritis
van den Berg, W. B. (2002) · Current Rheumatology Reports · doi:10.1007/s11926-002-0070-5 · Cited by 52
Signalling Pathways in B Cells: Implications for Autoimmunity
Dörner, T., & Lipsky, P. E. (2006) · Springer eBooks · doi:10.1007/3-540-29714-6_11 · Cited by 42
The role of mesenchymal cells in the pathophysiology of inflammatory arthritis
Meyer, L.-H., Franssen, L., & Pap, T. (2006) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2006.06.005 · Cited by 42
Rönnelid, J., Berg, L., Rogberg, S., Nilsson, A., Albertsson, K., & Klareskog, L. (1998) · Lara D. Veeken · doi:10.1093/rheumatology/37.1.7 · Cited by 40
Chemokine blockade: a new era in the treatment of rheumatoid arthritis?
Haringman, J. J., & Tak, P. P. (2004) · Arthritis Research · doi:10.1186/ar1172 · Cited by 35
Even though T-cell-directed trials have been of limited success, is there reason for optimism?
Panayi, G. S. (2006) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0094 · Cited by 27
Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus
Gergely, P., Grossman, C., Niland, B., Puskas, F., Neupane, H., Allam, F., Banki, K., Phillips, P. E., & Perl, A. (2002) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200201)46:1 · Cited by 5
Ho (2001) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200110)44:10 · Cited by 3
Gravellese (2000) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200002)43:2 · Cited by 2
Shigeyama (2000) · doi:10.1002/1529-0131(200011)43:11
Cited by
The Pathogenesis of Rheumatoid Arthritis
McInnes, I. B., & Schett, G. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1004965 · Cited by 5,514
Self-citationIL-6 as a keystone cytokine in health and disease
Hunter, C. A., & Jones, S. A. (2015) · Nature Immunology · doi:10.1038/ni.3153 · Cited by 2,511
Zhang, X., Zhang, D., Jia, H., Feng, Q., Wang, D., Liang, D., Wu, X., Li, J., Tang, L., Li, Y., et al. (2015) · Nature Medicine · doi:10.1038/nm.3914 · Cited by 1,690
Structure and signalling in the IL-17 receptor family
Gaffen, S. L. (2009) · Nature reviews. Immunology · doi:10.1038/nri2586 · Cited by 1,475
Colony-stimulating factors in inflammation and autoimmunity
Hamilton, J. A. (2008) · Nature reviews. Immunology · doi:10.1038/nri2356 · Cited by 1,305
“Therapeutic implications of targeting CSFs Clinical trials involving GM-CSF and M-CSF blockade have recently commenced in patients with rheumatoid arthritis ( Table 1 ), although there seems to be limited awareness generally of the potential relevance of the CSFs to its pathogenesi”
Background
Metadata
- Authors
- McInnes, I. B., & Schett, G.
- Venue
- Nature Reviews Immunology
- Published
- 2007-06
- Volume
- 7
- Issue
- 6
- Pages
- 429-442
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2155702314
- Cited by
- 2,529
- References
- 126
- FWCI
- 12.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.